Pac Premier
Giving Guide
You are here:  Home  >  Biotech  >  Current Article

Cure Pharmaceutical acquiring Chemistry Holdings

By   /   Monday, April 1st, 2019  /   Comments Off on Cure Pharmaceutical acquiring Chemistry Holdings

    Print       Email
Oxnard-based medical cannabis and drug delivery company Cure Pharmaceutical announced an all-stock deal April 1 to acquire Santa Monica seed-stage firm Chemistry Holdings. Cure said it would receive $2 million from Chemistry Holdings, in exchange for convertible notes, which would turn into around 600,000 shares of Cure stock at $3.34 per share if the deal…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email